Review



map2  (Synaptic Systems)


Bioz Verified Symbol Synaptic Systems is a verified supplier
Bioz Manufacturer Symbol Synaptic Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Synaptic Systems map2
    Map2, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 97/100, based on 295 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map2/188+004/pm42982811-424-10-12
    Average 97 stars, based on 295 article reviews
    map2 - by Bioz Stars, 2026-11
    97/100 stars

    Images

    Related Articles

    Blocking Assay:

    Article Title: Synaptobrevin‐2 Containing Extracellular Vesicles Are Rapidly Incorporated Into Mammalian Neurons via a Dynamin‐Dependent Pathway
    Article Snippet: .. After blocking with 3% BSA, primary antibodies against GFP (1:150) (Invitrogen, Cat. No. A11122, RRID:AB_221569), Syn1 (1:500) (Synaptic Systems, Cat. No. 106011, RRID:AB_10805139), Syp1 (1:500) (Synaptic Systems, Cat. No. 101006, RRID: AB_2622239), and/or MAP2 (1:1000) (Synaptic Systems, Cat. No. 188004, RRID:AB_2138181) were diluted in blocking buffer and incubated overnight at 4°C in a humid chamber. ..

    Incubation:

    Article Title: Synaptobrevin‐2 Containing Extracellular Vesicles Are Rapidly Incorporated Into Mammalian Neurons via a Dynamin‐Dependent Pathway
    Article Snippet: .. After blocking with 3% BSA, primary antibodies against GFP (1:150) (Invitrogen, Cat. No. A11122, RRID:AB_221569), Syn1 (1:500) (Synaptic Systems, Cat. No. 106011, RRID:AB_10805139), Syp1 (1:500) (Synaptic Systems, Cat. No. 101006, RRID: AB_2622239), and/or MAP2 (1:1000) (Synaptic Systems, Cat. No. 188004, RRID:AB_2138181) were diluted in blocking buffer and incubated overnight at 4°C in a humid chamber. ..

    Article Title: BIN1 gain-of-function in the presynaptic compartment leads to isoform-specific synaptotoxicity
    Article Snippet: .. Cells were incubated with 5% normal donkey serum for 2 h at RT before overnight incubation with the following primary antibodies: BIN1 (Millipore Cat# 05-449, RRID: AB_309738), Homer1 (Synaptic Systems Cat# 160 004, RRID: AB_10549720), MAP2 (Synaptic Systems Cat# 188 006, RRID: AB_2619881). .. The cells were then washed 3× with PBS and incubated with the following secondary antibodies raised in donkey: AlexaFluor-conjugated AffiniPure Fragment 405, 594, or 647 (Jackson ImmunoResearch).

    Article Title: Disrupted O-GalNAc glycosylation as a mechanism and biomarker of SLC35A2 -associated epilepsy
    Article Snippet: .. The samples were incubated in TBS-T for one hour with the following antibodies and lectins: Map2 (Synaptic Systems, #188011, 1:500) and biotinylated-VVA (Vector Labs #B-1235-2, 2mg/mL). .. To confirm specificity of lectin binding, hapten controls were performed by incubating VVA with N-Acetyl-D-Galactosamine (200mM; Cayman Chemicals, #31728) for 30 minutes prior to its use in primary incubation.

    Recombinant:

    Article Title: SNAP47 Silencing Impairs the Morphology and Neurotransmission of Hippocampal GABAergic Neurons
    Article Snippet: MAP2 , Millipore MAB 3418 , Purified mouse (monoclonal IgG1) , 1:100 , Bovine brain microtubule protein. .. MAP2 , SYSY 188,004 , Guinea pig (polyclonal antiserum) , 1:1000 , Recombinant protein corresponding to residues near the amino terminus of human Map2. ..



    Similar Products

    96
    Novus Biologicals chicken anti map2
    Chicken Anti Map2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map2/MAP2+Antibody/bio_rxiv__64898__2026__11__04__764401-368-80-82
    Average 96 stars, based on 1 article reviews
    chicken anti map2 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    97
    Synaptic Systems map2
    Map2, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map2/188+004/pm42982811-424-10-12
    Average 97 stars, based on 1 article reviews
    map2 - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    96
    PhosphoSolutions antibodies against microtubule associated protein 2
    a) Representative light microscopy images of hiPSC-derived autosomal dominant AD COs treated with 1 or 10 µM imipramine or Dulbecco’s Phosphate Buffered Saline (DPBS) as a negative control. Scale bar = 1 mm. b) Volumes of AD COs, estimated from measured perimeters and assuming a spherical shape. hiPSCs were derived from one female with APPdup (circles) and one male with APPV717I (triangles). Each symbol represents an individual CO. c) APP levels in AD CO tissue lysates measured by immunoblotting, relative to β-actin levels. d) Aβ levels in AD CO tissue lysates measured by immunoblotting, relative to β-actin levels. One-way ANOVA with Holm-Sidak post-hoc testing. e) Representative immunohistochemistry (IHC) images of AD COs derived from a male with APPV717I, immunolabeled for glial fibrillary acidic protein (GFAP) and microtubule associated <t>protein</t> <t>2</t> <t>(MAP2)</t> and counterstained with DAPI. Scale bar = 100 µm. f) Quantification of GFAP + astrocytic area fraction in AD COs. One-way ANOVA with Holm-Sidak post-hoc testing. g) Quantification of MAP2 + neuronal area fraction in AD COs. One-way ANOVA with Holm-Sidak post-hoc testing.
    Antibodies Against Microtubule Associated Protein 2, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map2/Anti+Microtubule+Associated+Protein+2+(MAP2)+Antibody/bio_rxiv__64898__2026__10__28__762584-71-7-13
    Average 96 stars, based on 1 article reviews
    antibodies against microtubule associated protein 2 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Proteintech anti map2

    Anti Map2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map2/MAP2+Antibody/pmc13756106-34-0-2
    Average 96 stars, based on 1 article reviews
    anti map2 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Synaptic Systems chicken anti map2

    Chicken Anti Map2, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map2/188+006/bio_rxiv__64898__2026__10__26__761842-118-25-27
    Average 94 stars, based on 1 article reviews
    chicken anti map2 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Proteintech map2

    Map2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map2/MAP2+Antibody/pm42961718-93-18-20
    Average 96 stars, based on 1 article reviews
    map2 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Proteintech map 2
    Antibodies used in the study.
    Map 2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map2/MAP2+Antibody/pmc13755753-12-0-8
    Average 96 stars, based on 1 article reviews
    map 2 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Novus Biologicals map2
    (A) Increased tau phosphorylation in dendrites <t>(MAP2+)</t> with 20 µm bicuculline treatment. (B) Schema of hippocampal excitatory neuron subtyping for colocalization with phospho-tau. (C) Increased tau phosphorylation at S202/T205 is induced by bicuculline specifically in excitatory pyramidal neurons (NeuroD6+) but not altered by TTX. (D) pT231 tau phosphorylation is not altered by changes in neuronal activity. Bic, bicuculline; TTX, tetrodotoxin. Scale bar is 25 µm. Neurons quantified in each condition are indicated in
    Map2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map2/MAP2+Antibody/bio_rxiv__64898__2026__10__26__762028-36-33-35
    Average 96 stars, based on 1 article reviews
    map2 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    97
    Synaptic Systems guinea pig anti map2
    (A) Increased tau phosphorylation in dendrites <t>(MAP2+)</t> with 20 µm bicuculline treatment. (B) Schema of hippocampal excitatory neuron subtyping for colocalization with phospho-tau. (C) Increased tau phosphorylation at S202/T205 is induced by bicuculline specifically in excitatory pyramidal neurons (NeuroD6+) but not altered by TTX. (D) pT231 tau phosphorylation is not altered by changes in neuronal activity. Bic, bicuculline; TTX, tetrodotoxin. Scale bar is 25 µm. Neurons quantified in each condition are indicated in
    Guinea Pig Anti Map2, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map2/188+004/bio_rxiv__64898__2026__10__26__761988-37-71-76
    Average 97 stars, based on 1 article reviews
    guinea pig anti map2 - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    Image Search Results


    a) Representative light microscopy images of hiPSC-derived autosomal dominant AD COs treated with 1 or 10 µM imipramine or Dulbecco’s Phosphate Buffered Saline (DPBS) as a negative control. Scale bar = 1 mm. b) Volumes of AD COs, estimated from measured perimeters and assuming a spherical shape. hiPSCs were derived from one female with APPdup (circles) and one male with APPV717I (triangles). Each symbol represents an individual CO. c) APP levels in AD CO tissue lysates measured by immunoblotting, relative to β-actin levels. d) Aβ levels in AD CO tissue lysates measured by immunoblotting, relative to β-actin levels. One-way ANOVA with Holm-Sidak post-hoc testing. e) Representative immunohistochemistry (IHC) images of AD COs derived from a male with APPV717I, immunolabeled for glial fibrillary acidic protein (GFAP) and microtubule associated protein 2 (MAP2) and counterstained with DAPI. Scale bar = 100 µm. f) Quantification of GFAP + astrocytic area fraction in AD COs. One-way ANOVA with Holm-Sidak post-hoc testing. g) Quantification of MAP2 + neuronal area fraction in AD COs. One-way ANOVA with Holm-Sidak post-hoc testing.

    Journal: bioRxiv

    Article Title: Imipramine binds to amyloid-β and extends the survival of Alzheimer’s disease patients

    doi: 10.64898/2026.10.28.762584

    Figure Lengend Snippet: a) Representative light microscopy images of hiPSC-derived autosomal dominant AD COs treated with 1 or 10 µM imipramine or Dulbecco’s Phosphate Buffered Saline (DPBS) as a negative control. Scale bar = 1 mm. b) Volumes of AD COs, estimated from measured perimeters and assuming a spherical shape. hiPSCs were derived from one female with APPdup (circles) and one male with APPV717I (triangles). Each symbol represents an individual CO. c) APP levels in AD CO tissue lysates measured by immunoblotting, relative to β-actin levels. d) Aβ levels in AD CO tissue lysates measured by immunoblotting, relative to β-actin levels. One-way ANOVA with Holm-Sidak post-hoc testing. e) Representative immunohistochemistry (IHC) images of AD COs derived from a male with APPV717I, immunolabeled for glial fibrillary acidic protein (GFAP) and microtubule associated protein 2 (MAP2) and counterstained with DAPI. Scale bar = 100 µm. f) Quantification of GFAP + astrocytic area fraction in AD COs. One-way ANOVA with Holm-Sidak post-hoc testing. g) Quantification of MAP2 + neuronal area fraction in AD COs. One-way ANOVA with Holm-Sidak post-hoc testing.

    Article Snippet: Human CO sections were incubated with primary antibodies against microtubule-associated protein 2 (MAP2; PhosphoSolutions, 1:1,000) and glial fibrillary acidic protein (GFAP; Millipore, 1:500), and rat brain sections were incubated with primary antibodies against tau paired helical filaments (PHF1; Dr. Peter Davies, 1:50), or neuronal nuclei (NeuN; Abcam, 1:500), all diluted in staining buffer (0.1% Triton X-100 and 3% BSA in DPBS) and incubated in the dark overnight at 4 °C.

    Techniques: Light Microscopy, Derivative Assay, Saline, Negative Control, Tissue, Western Blot, Immunohistochemistry, Immunolabeling

    Journal: iScience

    Article Title: RBM42 couples alternative splicing to cytoskeletal organization to direct cortical development

    doi: 10.1016/j.isci.2026.118059

    Figure Lengend Snippet:

    Article Snippet: Anti-MAP2 , Proteintech , Cat#17490-1-AP; RRID: AB_2137880.

    Techniques:

    Antibodies used in the study.

    Journal: Frontiers in Pharmacology

    Article Title: Astragaloside IV ameliorates cognitive impairment after traumatic brain injury with involvement of NMDAR-related signaling

    doi: 10.3389/fphar.2026.1925675

    Figure Lengend Snippet: Antibodies used in the study.

    Article Snippet: MAP-2 , Rabbit , 1:200 , IF , Proteintech , 17490-1-AP , AB_2137880.

    Techniques:

    AS-IV preserves MAP-2 and promotes its recovery after TBI. (A) Immunofluorescence staining of MAP-2 in cortical neurons (scale bar: 50 μm; n = 3). (B) Immunofluorescence staining of PSD-95 in cortical neurons (scale bar: 100 μm; n = 3). (C) Quantification of relative cortical MAP-2 fluorescence intensity. (D) Quantification of relative cortical PSD-95 fluorescence intensity. Data are mean ± SEM; n = 3 mice per group. *p < 0.05, **p < 0.01, ***p < 0.001; ns, not significant. Sham and TBI groups received the matched drug-free vehicle.

    Journal: Frontiers in Pharmacology

    Article Title: Astragaloside IV ameliorates cognitive impairment after traumatic brain injury with involvement of NMDAR-related signaling

    doi: 10.3389/fphar.2026.1925675

    Figure Lengend Snippet: AS-IV preserves MAP-2 and promotes its recovery after TBI. (A) Immunofluorescence staining of MAP-2 in cortical neurons (scale bar: 50 μm; n = 3). (B) Immunofluorescence staining of PSD-95 in cortical neurons (scale bar: 100 μm; n = 3). (C) Quantification of relative cortical MAP-2 fluorescence intensity. (D) Quantification of relative cortical PSD-95 fluorescence intensity. Data are mean ± SEM; n = 3 mice per group. *p < 0.05, **p < 0.01, ***p < 0.001; ns, not significant. Sham and TBI groups received the matched drug-free vehicle.

    Article Snippet: MAP-2 , Rabbit , 1:200 , IF , Proteintech , 17490-1-AP , AB_2137880.

    Techniques: Immunofluorescence, Staining, Fluorescence

    Effects of NMDAR antagonists on AS-IV-mediated MAP-2 recovery in the cortex and hippocampus after TBI. (A) Representative MAP-2 immunofluorescence images in the cortex across the five groups (scale bar: 50 μm; n = 3). (B) Representative MAP-2 immunofluorescence images in the hippocampal dentate gyrus (DG) across the five groups (scale bar: 50 μm; n = 3). (C) Quantification of relative MAP-2 fluorescence intensity in the cortex. (D) Quantification of relative MAP-2 fluorescence intensity in the DG. Data are mean ± SEM; n = 3 mice per group. *p < 0.05, **p < 0.01, ***p < 0.001; ns, not significant. Sham and TBI groups received the matched drug-free vehicle; groups not receiving MK-801 or TCN-201 received corresponding PBS injections during the antagonist-treatment period.

    Journal: Frontiers in Pharmacology

    Article Title: Astragaloside IV ameliorates cognitive impairment after traumatic brain injury with involvement of NMDAR-related signaling

    doi: 10.3389/fphar.2026.1925675

    Figure Lengend Snippet: Effects of NMDAR antagonists on AS-IV-mediated MAP-2 recovery in the cortex and hippocampus after TBI. (A) Representative MAP-2 immunofluorescence images in the cortex across the five groups (scale bar: 50 μm; n = 3). (B) Representative MAP-2 immunofluorescence images in the hippocampal dentate gyrus (DG) across the five groups (scale bar: 50 μm; n = 3). (C) Quantification of relative MAP-2 fluorescence intensity in the cortex. (D) Quantification of relative MAP-2 fluorescence intensity in the DG. Data are mean ± SEM; n = 3 mice per group. *p < 0.05, **p < 0.01, ***p < 0.001; ns, not significant. Sham and TBI groups received the matched drug-free vehicle; groups not receiving MK-801 or TCN-201 received corresponding PBS injections during the antagonist-treatment period.

    Article Snippet: MAP-2 , Rabbit , 1:200 , IF , Proteintech , 17490-1-AP , AB_2137880.

    Techniques: Immunofluorescence, Fluorescence

    (A) Increased tau phosphorylation in dendrites (MAP2+) with 20 µm bicuculline treatment. (B) Schema of hippocampal excitatory neuron subtyping for colocalization with phospho-tau. (C) Increased tau phosphorylation at S202/T205 is induced by bicuculline specifically in excitatory pyramidal neurons (NeuroD6+) but not altered by TTX. (D) pT231 tau phosphorylation is not altered by changes in neuronal activity. Bic, bicuculline; TTX, tetrodotoxin. Scale bar is 25 µm. Neurons quantified in each condition are indicated in

    Journal: bioRxiv

    Article Title: Neuronal Hyperactivity Induces Tau Phosphorylation Selectively in Excitatory Pyramidal Neurons Which Contributes to GluA2 Regulation

    doi: 10.64898/2026.10.26.762028

    Figure Lengend Snippet: (A) Increased tau phosphorylation in dendrites (MAP2+) with 20 µm bicuculline treatment. (B) Schema of hippocampal excitatory neuron subtyping for colocalization with phospho-tau. (C) Increased tau phosphorylation at S202/T205 is induced by bicuculline specifically in excitatory pyramidal neurons (NeuroD6+) but not altered by TTX. (D) pT231 tau phosphorylation is not altered by changes in neuronal activity. Bic, bicuculline; TTX, tetrodotoxin. Scale bar is 25 µm. Neurons quantified in each condition are indicated in

    Article Snippet: Primary antibodies and dilutions used in this study were 1:1000 total tau (ab76128, Abcam, Cambridge, UK), 1:1000 phospho-tau S202/T205 (MN1020, ThermoFisher, Waltham, MA, USA), 1:1000 phosphotau T231 (MN1040, ThermoFisher, Waltham, MA, USA), 1:1000 MAP2 (NB300-213, Novus Biologicals, Centennial, CO, USA), 1:400 CTIP2 (AB18465, Abcam, Cambridge, UK), 1:400 NeuroD6 (AB85824, Abcam, Cambridge, UK), 1:150 GAD67 (sc28376, Santa Cruz Biotechnology, Dallas, TX, USA), 1:2000 GFP (ab13970, Abcam, Cambridge, UK), 1:2000 Myc (clone 2235, Huganir lab), 1:1000 GluA2 (purified 15F1, Gouaux lab( )), and 1:500 cfos (226008, Synaptic Systems, Göttingen, Germany).

    Techniques: Phospho-proteomics, Activity Assay